4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000950170-23-053818
Options or other derivatives
- Chief Executive Officer acquired 77,500 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kulkarni Samarth Chief Executive Officer | 2023-10-13 | Grant or award · Stock Option (Right to Buy) | +52,500 | 52,500 | D: show line 1 in the form | ||
| Kulkarni Samarth Chief Executive Officer | 2023-10-13 | Grant or award · Restricted Stock Unit | +25,000 | 25,000 | D: show line 2 in the form |
Loading xslF345X05/ownership.xml…